Pheton Holdings Ltd (NASDAQ:PTHL) Short Interest Down 29.4% in December

Pheton Holdings Ltd (NASDAQ:PTHL) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totaling 17,067 shares, a decrease of 29.4% from the December 15th total of 24,161 shares. Based on an average daily volume of 68,493 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the shares of the company are short sold. Approximately 0.3% of the shares of the company are short sold. Based on an average daily volume of 68,493 shares, the short-interest ratio is currently 0.2 days.

Pheton Trading Down 32.5%

Shares of Pheton stock traded down $0.29 on Friday, reaching $0.61. The stock had a trading volume of 1,802,629 shares, compared to its average volume of 3,792,516. The business’s 50 day moving average is $0.54 and its two-hundred day moving average is $3.43. Pheton has a 1 year low of $0.39 and a 1 year high of $32.00.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on PTHL shares. Wall Street Zen upgraded Pheton from a “sell” rating to a “hold” rating in a research note on Sunday, September 21st. Weiss Ratings reiterated a “sell (e+)” rating on shares of Pheton in a research note on Friday, October 31st. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.